Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
FibroBiologics Inc. (FBLG) had Operating Cash Flow per Share of $-0.36 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-11.16M |
|
-- |
|
-- |
|
$13.74M |
|
$-13.74M |
|
$2.58M |
|
$-11.16M |
|
$-11.16M |
|
$-11.16M |
|
$-11.16M |
|
$-11.16M |
|
$-11.16M |
|
$-13.74M |
|
$-13.16M |
|
32.88M |
|
32.88M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$14.23M |
|
$0.82M |
|
$2.22M |
|
$16.45M |
|
$12.73M |
|
-- |
|
$0.98M |
|
$13.71M |
|
$2.73M |
|
$2.73M |
|
$2.73M |
|
35.09M |
|
| Cash Flow Statement Financials | |
$-11.90M |
|
$-0.18M |
|
$16.91M |
|
$9.16M |
|
$13.98M |
|
$4.82M |
|
$2.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
-- |
|
3.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-408.08% |
|
-408.08% |
|
-67.87% |
|
-408.08% |
|
$0.08 |
|
$-0.37 |
|
|
Operating Cash Flow per Share |
$-0.36 |